U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07310537) titled 'Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling' on Dec. 16.
Brief Summary: The goal of this observational study is to investigate whether circulating tumor-derived DNA (ctDNA) can be reliably detected and analyzed in blood obtained through automated capillary sampling in adult patients (>=21 years) with colorectal liver metastases (CRLM).
The main question it aims to answer is:
* Can ctDNA be detected in small volumes of capillary blood collected using an automated sampling device?
* Do ctDNA levels measured in capillary blood agree with those measured in venous blood from the same...